☆ 4.8 Letter

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2

CELL RESEARCH (2020)

Get Full Text
Add to Collection

Journal

CELL RESEARCH
Volume 30, Issue 10, Pages 932-935

Publisher

SPRINGERNATURE
DOI: 10.1038/s41422-020-0387-5

Keywords

-

Categories

Cell Biology

Funding

  1. National Institutes of Health (NIH) [R01AI137472, R01AI139092]
  2. New York Blood Center funds [VIM-NYB616, VIM-NYB673]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.